KIR2DL2
Killer cell immunoglobulin-like receptor 2DL2
Also known as: KI2L2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for KIR2DL2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>P43627|KIR2DL2
1 MSLMVVSMAC VGFFLLQGAW PHEGVHRKPS LLAHPGRLVK SEETVILQCW SDVRFEHFLL
61 HREGKFKDTL HLIGEHHDGV SKANFSIGPM MQDLAGTYRC YGSVTHSPYQ LSAPSDPLDI
121 VITGLYEKPS LSAQPGPTVL AGESVTLSCS SRSSYDMYHL SREGEAHECR FSAGPKVNGT
181 FQADFPLGPA THGGTYRCFG SFRDSPYEWS NSSDPLLVSV IGNPSNSWPS PTEPSSKTGN
241 PRHLHILIGT SVVIILFILL FFLLHRWCSN KKNAAVMDQE SAGNRTANSE DSDEQDPQEV
301 TYTQLNHCVF TQRKITRPSQ RPKTPPTDII VYAELPNAES RSKVVSCPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KIR2DL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KIR2DL2 as an antibody target. Whether an autoantibody or antibody against KIR2DL2 could matter depends on whether native KIR2DL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KIR2DL2 is annotated at the cell surface, where native KIR2DL2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KIR2DL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...